Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Single Centre, Open label, Single Arm, Phase I Study to evaluate the Tolerability, Safety and Immunogenicity of a 15-Valent Pneumococcal Conjugate Vaccine (PCV15) in healthy subjects between 18-45 years of age - 15-Valent Pneumococcal Conjugate Vaccine (PCV15)

Trial Profile

A Single Centre, Open label, Single Arm, Phase I Study to evaluate the Tolerability, Safety and Immunogenicity of a 15-Valent Pneumococcal Conjugate Vaccine (PCV15) in healthy subjects between 18-45 years of age - 15-Valent Pneumococcal Conjugate Vaccine (PCV15)

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Jul 2018

At a glance

  • Drugs V 114 (Primary)
  • Indications Pneumonia
  • Focus Adverse reactions
  • Sponsors Aurobindo Pharma
  • Most Recent Events

    • 22 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top